(Approval lapsed) Piperacillin and Tazobactam for injection USP (4g piperacillin/ 0.5g tazobactam) X-GEN
Section 19A approved medicine
(Approval lapsed) Piperacillin and Tazobactam for injection USP (4g piperacillin/ 0.5g tazobactam) X-GEN
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Expired
Medicines in short supply/unavailable
PIPERTAZ SANDOZ 4 g/ 0.5 g piperacillin (as sodium) 4g and tazobactam (as sodium) 0.5 g powder for injection bottle - ARTG 140840
Indication(s)
Piperacillin and Tazobactam for Injection is indicated for the treatment of patients with moderate to severe infections caused by susceptible isolates of the designated bacteria in the conditions listed below:
- Lower respiratory tract infections;
- Intra-abdominal infections;
- Skin and skin structure infections;
- Bacterial septicaemia;
- Gynaecological infections.
In hospitalised children aged 2 to 12 years, it is indicated for the treatment of serious intra-abdominal infections.